HomeOpen Access News

Open Access News

Powering net zero in housing and healthcare

Steve Norman from Sustain Commercial Solar Ltd guides us through a smarter approach to sustainability when it comes to powering net zero in housing and healthcare.

Researchers investigate the genetics of eating disorders

An international research team have discovered that the genetics of eating disorders and some psychiatric disorders have some similarities, raising new questions about treatment for both.

Energy poverty on the rise, according to new findings

Auriga Services Ltd collected data from 500 people through a Google Survey and found that energy poverty has increased during lockdown.

Subtle ovarian cancer symptoms that should not be missed

In recognition of Ovarian Cancer Awareness Month, Dr Nicky Keay, Chief Medical Officer at Forth and expert in endocrinology and women’s health problems, takes a look at some of the most common symptoms that too often get overlooked.

Scientists find that elevated neutrophils can predict severe COVID and death

Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.

Intensive fish farming: A call to reform the industry

Sophie Peutrill, Global Campaign Manager – Fish Welfare at Compassion in World Farming, argues that intensive fish farming is unsustainable and unethical and we must do more to reform this growing industry.

Israel will now vaccinate Palestinians who have permits to work 

Israel faced international criticism on their refusal to vaccine Palestinians - now, the country will begin rolling out Pfizer shots to some Palestinians who have work permits.

Using the private sector to recover supplier overpayment

Glenn St. John-Colgan, Managing Partner at Augmentas Group, takes a look at a recent UK initiative to recover money owed from suppliers and considers its implications.

FDA approves the Johnson & Johnson vaccine for use

The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.

The Brazilian COVID mutation has been found in the UK

The UK has found six confirmed cases of the Brazilian COVID mutation yesterday (28 February) - but an individual who tested positive three weeks ago is still being traced throughout the country.

Invasions threaten sustainable late blight control

Andrivon Didier, Research Director at INRAE, France’s new National Research Institute for Agriculture, Food and Environment, discusses the need for sustainable late blight control despite the threat of new evolving invaders.

45% of people living with obesity have healthy blood pressure

Scientists have discovered that up to 45% of people living with obesity have healthy blood pressure, glucose and lipid levels - protecting them from the risk of cardiovascular disease.

Why the government’s £50m cash injection doesn’t go far enough

"By failing students, the wider economy suffers", says Lydia Jones, CEO and Founder of Housemates. Here she provides insight into how badly students have been affected by the pandemic and how the lack of government funding has negatively impacted student accommodation operators.

Arthritis impacts six million Canadians and counting

Dr Siân Bevan, Chief Science Officer of the Arthritis Society describes how arthritis impacts six million Canadians and counting.

Huntington’s disease: Present concern & therapeutic view

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.

The window for convalescent plasma donation is just under two months

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

What are the priority groups for phase two of UK vaccinations?

The Government unveiled the confirmed priority groups for phase two of UK vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) is choosing age as the deciding factor.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders